Showing results (51-60 of 106) with videos related to
Sort By:
Pageof 11
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.Transplantation Direct|March 6, 2023
Performance of a Prospective Anticoagulation Stratification Algorithm After Liver TransplantationJorge Sanchez-Garcia, Fidel Lopez-Verdugo, Spencer LeCorchick, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2014
Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolismScott C Woller, Scott M Stevens, Steven Towner, et al.The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.Annals of Internal Medicine|October 2, 2023
In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulationAnna L Parks, Scott M StevensClinics in Chest Medicine|November 5, 2010
Deep vein thrombosis prophylaxis in hospitalized medical patients: current recommendations, general rates of implementation, and initiatives for improvementScott M Stevens, James D DouketisChest|February 13, 2016
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel ReportClive Kearon, Elie A Akl, Joseph Ornelas, et al.Pageof 11